Role of Pht proteins in attachment of Streptococcus pneumoniae to respiratory epithelial cells

Infection and Immunity

Volumn 82, Issue 4, 2014, Pages 1683-1691

  Kallio, Anna ^a   Sepponen, Kirsi ^a,c   Hermand, Philippe ^b   Denoël, Philippe ^b   Godfroid, Fabrice ^b   Melin, Merit ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b GSK   (Belgium)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PHT D PROTEIN; PHT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ALVEOLUS CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; RESPIRATORY EPITHELIUM; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; WILD TYPE;

ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; BACTERIAL ADHESION; BACTERIAL PROTEINS; CELL LINE, TUMOR; EPITHELIAL CELLS; HUMANS; HYDROLASES; RESPIRATORY MUCOSA; STREPTOCOCCUS PNEUMONIAE; VIRULENCE;

EID: 84896462983     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00699-13     Document Type: Article

References (57)

1. Anderton JM, Rajam G, Romero-Steiner S, Summer S, Kowalczyk AP, Carlone GM, Sampson JS, Ades EW. 2007. E-cadherin is a receptor for the common protein pneumococcal surface adhesin A (PsaA) of Streptococcus pneumoniae. Microb. Pathog. 42:225-236. http://dx.doi.org/10.1016/j.micpath.2007.02.003.
2. Bagnoli F, Moschioni M, Donati C, Dimitrovska V, Ferlenghi I, Facciotti C, Muzzi A, Giusti F, Emolo C, Sinisi A, Hilleringmann M, Pansegrau W, Censini S, Rappuoli R, Covacci A, Masignani V, Barocchi MA. 2008. A second pilus type in Streptococcus pneumoniae is prevalent in emerging serotypes and mediates adhesion to host cells. J. Bacteriol. 190:5480-5492. http://dx.doi.org/10.1128/JB.00384-08.
3. Khan MN, Sharma SK, Filkins LM, Pichichero ME. 2012. PcpA of Streptococcus pneumoniae mediates adherence to nasopharyngeal and lung epithelial cells and elicits functional antibodies in humans. Microbes Infect. 14:1102-1110. http://dx.doi.org/10.1016/j.micinf.2012.06.007.
4. King SJ, Hippe KR, Gould JM, Bae D, Peterson S, Cline RT, Fasching C, Janoff EN, Weiser JN. 2004. Phase variable desialylation of host proteins that bind to Streptococcus pneumoniae in vivo and protect the airway. Mol. Microbiol. 54:159-171. http://dx.doi.org/10.1111/j.1365-2958.2004.04252.x.
5. Lu L, Ma Y, Zhang JR. 2006. Streptococcus pneumoniae recruits complement factor H through the amino terminus of CbpA. J. Biol. Chem. 281:15464-15474. http://dx.doi.org/10.1074/jbc.M602404200.
6. Nelson AL, Ries J, Bagnoli F, Dahlberg S, Falker S, Rounioja S, Tschop J, Morfeldt E, Ferlenghi I, Hilleringmann M, Holden DW, Rappuoli R, Normark S, Barocchi MA, Henriques-Normark B. 2007. RrgA is a pilusassociated adhesin in Streptococcus pneumoniae. Mol. Microbiol. 66: 329-340. http://dx.doi.org/10.1111/j.1365-2958.2007.05908.x.
7. Zhang JR, Mostov KE, Lamm ME, Nanno M, Shimida S, Ohwaki M, Tuomanen E. 2000. The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell 102:827-837. http://dx.doi.org/10.1016/S0092-8674(00)00071-4.
8. Adamou JE, Heinrichs JH, Erwin AL, Walsh W, Gayle T, Dormitzer M, Dagan R, Brewah YA, Barren P, Lathigra R, Langermann S, Koenig S, Johnson S. 2001. Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis. Infect. Immun. 69:949-958. http://dx.doi.org/10.1128/IAI.69.2.949-958.2001.
9. Rioux S, Neyt C, Di Paolo E, Turpin L, Charland N, Labbe S, Mortier MC, Mitchell TJ, Feron C, Martin D, Poolman JT. 2011. Transcriptional regulation, occurrence and putative role of the Pht family of Streptococcus pneumoniae. Microbiology 157:336-348. http://dx.doi.org/10.1099/mic.0.042184-0.
10. Godfroid F, Hermand P, Verlant V, Denoel P, Poolman JT. 2011. Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens. Infect. Immun. 79:238-245. http://dx.doi.org/10.1128/IAI.00378-10.
11. Zhang Y, Masi AW, Barniak V, Mountzouros K, Hostetter MK, Green BA. 2001. Recombinant PhpA protein, a unique histidine motifcontaining protein from Streptococcus pneumoniae, protects mice against intranasal pneumococcal challenge. Infect. Immun. 69:3827-3836. http://dx.doi.org/10.1128/IAI.69.6.3827-3836.2001.
12. Hamel J, Charland N, Pineau I, Ouellet C, Rioux S, Martin D, Brodeur BR. 2004. Prevention of pneumococcal disease in mice immunized with conserved surface-accessible proteins. Infect. Immun. 72:2659-2670. http://dx.doi.org/10.1128/IAI.72.5.2659-2670.2004.
13. Wizemann TM, Heinrichs JH, Adamou JE, Erwin AL, Kunsch C, Choi GH, Barash SC, Rosen CA, Masure HR, Tuomanen E, Gayle A, Brewah YA, Walsh W, Barren P, Lathigra R, Hanson M, Langermann S, Johnson S, Koenig S. 2001. Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect. Immun. 69:1593-1598. http://dx.doi.org/10.1128/IAI.69.3.1593-1598.2001.
14. Denoel P, Philipp MT, Doyle L, Martin D, Carletti G, Poolman JT. 2011. A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae. Vaccine 29:5495-5501. http://dx.doi.org/10.1016/j.vaccine.2011.05.051.
15. Bologa M, Kamtchoua T, Hopfer R, Sheng X, Hicks B, Bixler G, Hou V, Pehlic V, Yuan T, Gurunathan S. 2012. Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein D vaccine. Vaccine 30:7461-7468. http://dx.doi.org/10.1016/j.vaccine.2012.10.076.
16. Seiberling M, Bologa M, Brookes R, Ochs M, Go K, Neveu D, Kamtchoua T, Lashley P, Yuan T, Gurunathan S. 2012. Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults. Vaccine 30:7455-7460. http://dx.doi.org/10.1016/j.vaccine.2012.10.080.
17. Kunitomo E, Terao Y, Okamoto S, Rikimaru T, Hamada S, Kawabata S. 2008. Molecular and biological characterization of histidine triad protein in group A streptococci. Microbes Infect. 10:414-423. http://dx.doi.org/10.1016/j.micinf.2008.01.003.
18. Reid SD, Montgomery AG, Voyich JM, DeLeo FR, Lei B, Ireland RM, Green NM, Liu M, Lukomski S, Musser JM. 2003. Characterization of an extracellular virulence factor made by group A Streptococcus with homology to the Listeria monocytogenes internalin family of proteins. Infect. Immun. 71:7043-7052. http://dx.doi.org/10.1128/IAI.71.12.7043-7052.2003.
19. Waldemarsson J, Areschoug T, Lindahl G, Johnsson E. 2006. The streptococcal Blr and Slr proteins define a family of surface proteins with leucine-rich repeats: camouflaging by other surface structures. J. Bacteriol. 188:378-388. http://dx.doi.org/10.1128/JB.188.2.378-388.2006.
20. Shao ZQ, Zhang YM, Pan XZ, Wang B, Chen JQ. 2013. Insight into the evolution of the histidine triad protein (HTP) family in Streptococcus. PLoS One 8:e60116. http://dx.doi.org/10.1371/journal.pone.0060116.
21. Bober M, Morgelin M, Olin AI, von Pawel-Rammingen U, Collin M. 2011. The membrane bound LRR lipoprotein Slr, and the cell wallanchored M1 protein from Streptococcus pyogenes both interact with type I collagen. PLoS One 6:e20345. http://dx.doi.org/10.1371/journal.pone.0020345.
22. Panina EM, Mironov AA, Gelfand MS. 2003. Comparative genomics of bacterial zinc regulons: enhanced ion transport, pathogenesis, and rearrangement of ribosomal proteins. Proc. Natl. Acad. Sci. U. S. A. 100:9912-9917. http://dx.doi.org/10.1073/pnas.1733691100.
23. 2+ limitation and the repressor/activator function of AdcR. Metallomics 3:609-618. http://dx.doi.org/10.1039/c1mt00030f.
24. Bunker VW, Hinks LJ, Lawson MS, Clayton BE. 1984. Assessment of zinc and copper status of healthy elderly people using metabolic balance studies and measurement of leucocyte concentrations. Am. J. Clin. Nutr. 40:1096-1102.
25. Harlyk C, Mccourt J, Bordin G, Rodriguez AR, van der Eeckhout A. 1997. Determination of copper, zinc and iron in broncho-alveolar lavages by atomic absorption spectroscopy. J. Trace Elem. Med. Biol. 11:137-142. http://dx.doi.org/10.1016/S0946-672X(97)80040-5.
26. Spellerberg B, Rozdzinski E, Martin S, Weber-Heynemann J, Schnitzler N, Lutticken R, Podbielski A. 1999. Lmb, a protein with similarities to the LraI adhesin family, mediates attachment of Streptococcus agalactiae to human laminin. Infect. Immun. 67:871-878.
27. Melin M, Di Paolo E, Tikkanen L, Jarva H, Neyt C, Kayhty H, Meri S, Poolman J, Vakevainen M. 2010. Interaction of pneumococcal histidine triad proteins with human complement. Infect. Immun. 78:2089-2098. http://dx.doi.org/10.1128/IAI.00811-09.
28. 2+-dependent repressor AdcR and inhibit complement deposition through the recruitment of complement factor H. FASEB J. 23:731-738. http://dx.doi.org/10.1096/fj.08-119537.
29. Khan MN, Pichichero ME. 2012. Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans. Vaccine 30:2900-2907. http://dx.doi.org/10.1016/j.vaccine.2012.02.023.
30. Balachandran P, Brooks-Walter A, Virolainen-Julkunen A, Hollingshead SK, Briles DE. 2002. Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae. Infect. Immun. 70:2526-2534. http://dx.doi.org/10.1128/IAI.70.5.2526-2534.2002.
31. Orihuela CJ, Gao G, Francis KP, Yu J, Tuomanen EI. 2004. Tissuespecific contributions of pneumococcal virulence factors to pathogenesis. J. Infect. Dis. 190:1661-1669. http://dx.doi.org/10.1086/424596.
32. Orihuela CJ, Radin JN, Sublett JE, Gao G, Kaushal D, Tuomanen EI. 2004. Microarray analysis of pneumococcal gene expression during invasive disease. Infect. Immun. 72:5582-5596. http://dx.doi.org/10.1128/IAI.72.10.5582-5596.2004.
33. Agarwal V, Asmat TM, Luo S, Jensch I, Zipfel PF, Hammerschmidt S. 2010. Complement regulator factor H mediates a two-step uptake of Streptococcus pneumoniae by human cells. J. Biol. Chem. 285:23486-23495. http://dx.doi.org/10.1074/jbc.M110.142703.
34. Hammerschmidt S, Agarwal V, Kunert A, Haelbich S, Skerka C, Zipfel PF. 2007. The host immune regulator factor H interacts via two contact sites with the PspC protein of Streptococcus pneumoniae and mediates adhesion to host epithelial cells. J. Immunol. 178:5848-5858.
35. Hammerschmidt S, Talay SR, Brandtzaeg P, Chhatwal GS. 1997. SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component. Mol. Microbiol. 25:1113-1124. http://dx.doi.org/10.1046/j.1365-2958.1997.5391899.x.
36. Quin LR, Onwubiko C, Moore QC, Mills MF, McDaniel LS, Carmicle S. 2007. FactorHbinding to PspC of Streptococcus pneumoniae increases adherence to human cell lines in vitro and enhances invasion of mouse lungs in vivo. Infect. Immun. 75:4082-4087. http://dx.doi.org/10.1128/IAI.00474-07.
37. Rosenow C, Ryan P, Weiser JN, Johnson S, Fontan P, Ortqvist A, Masure HR. 1997. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol. Microbiol. 25:819-829. http://dx.doi.org/10.1111/j.1365-2958.1997.mmi494.x.
38. Gould JM, Weiser JN. 2002. The inhibitory effect of C-reactive protein on bacterial phosphorylcholine platelet-activating factor receptor-mediated adherence is blocked by surfactant. J. Infect. Dis. 186:361-371. http://dx.doi.org/10.1086/341658.
39. Hava DL, Camilli A. 2002. Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol. Microbiol. 45:1389-1406. http://dx.doi.org/10.1046/j.1365-2958.2002.03106.x.
40. Plumptre CD, Ogunniyi AD, Paton JC. 2013. Surface association of Pht proteins of Streptococcus pneumoniae. Infect. Immun. 81:3644-3651. http://dx.doi.org/10.1128/IAI.00562-13.
41. Sanchez CJ, Hinojosa CA, Shivshankar P, Hyams C, Camberlein E, Brown JS, Orihuela CJ. 2011. Changes in capsular serotype alter the surface exposure of pneumococcal adhesins and impact virulence. PLoS One 6:e26587. http://dx.doi.org/10.1371/journal.pone.0026587.
42. Hammerschmidt S, Wolff S, Hocke A, Rosseau S, Muller E, Rohde M. 2005. Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells. Infect. Immun. 73:4653-4667. http://dx.doi.org/10.1128/IAI.73.8.4653-4667.2005.
43. Robson RL, Reed NA, Horvat RT. 2006. Differential activation of inflammatory pathways in A549 type II pneumocytes by Streptococcus pneumoniae strains with different adherence properties. BMC Infect. Dis. 6:71. http://dx.doi.org/10.1186/1471-2334-6-71.
44. Paterson GK, Nieminen L, Jefferies JM, Mitchell TJ. 2008. PclA, a pneumococcal collagen-like protein with selected strain distribution, contributes to adherence and invasion of host cells. FEMS Microbiol. Lett. 285:170-176. http://dx.doi.org/10.1111/j.1574-6968.2008.01217.x.
45. Kim JO, Weiser JN. 1998. Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J. Infect. Dis. 177:368-377. http://dx.doi.org/10.1086/514205.
46. Weiser JN, Austrian R, Sreenivasan PK, Masure HR. 1994. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect. Immun. 62:2582-2589.
47. Overweg K, Pericone CD, Verhoef GG, Weiser JN, Meiring HD, De Jong AP, De Groot R, Hermans PW. 2000. Differential protein expression in phenotypic variants of Streptococcus pneumoniae. Infect. Immun. 68:4604-4610. http://dx.doi.org/10.1128/IAI.68.8.4604-4610.2000.
48. Weiser JN, Markiewicz Z, Tuomanen EI, Wani JH. 1996. Relationship between phase variation in colony morphology, intrastrain variation in cell wall physiology, and nasopharyngeal colonization by Streptococcus pneumoniae. Infect. Immun. 64:2240-2245.
49. Berry AM, Paton JC. 1996. Sequence heterogeneity of PsaA, a 37-kilodalton putative adhesin essential for virulence of Streptococcus pneumoniae. Infect. Immun. 64:5255-5262.
50. Romero-Steiner S, Pilishvili T, Sampson JS, Johnson SE, Stinson A, Carlone GM, Ades EW. 2003. Inhibition of pneumococcal adherence to human nasopharyngeal epithelial cells by anti-PsaA antibodies. Clin. Diagn. Lab. Immunol. 10:246-251. http://dx.doi.org/10.1128/CDLI.10.2.246-251.2003.
51. Briles DE, Ades E, Paton JC, Sampson JS, Carlone GM, Huebner RC, Virolainen A, Swiatlo E, Hollingshead SK. 2000. Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. Infect. Immun. 68:796-800. http://dx.doi.org/10.1128/IAI.68.2.796-800.2000.
52. De BK, Sampson JS, Ades EW, Huebner RC, Jue DL, Johnson SE, Espina M, Stinson AR, Briles DE, Carlone GM. 2000. Purification and characterization of Streptococcus pneumoniae palmitoylated pneumococcal surface adhesin A expressed in Escherichia coli. Vaccine 18:1811-1821. http://dx.doi.org/10.1016/S0264-410X(99)00481-8.
53. Wu HY, Nahm MH, Guo Y, Russell MW, Briles DE. 1997. Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae. J. Infect. Dis. 175:839-846. http://dx.doi.org/10.1086/513980.
54. Briles DE, Hollingshead S, Brooks-Walter A, Nabors GS, Ferguson L, Schilling M, Gravenstein S, Braun P, King J, Swift A. 2000. The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection. Vaccine 18:1707-1711. http://dx.doi.org/10.1016/S0264-410X(99)00511-3.
55. Avery OT, Macleod CM, McCarty M. 1944. Studies on the chemical nature of the substance inducing transformation of pneumococcal types: induction of transformation by a desoxyribonucleic acid fraction isolated from Pneumococcus type Iii. J. Exp. Med. 79:137-158. http://dx.doi.org/10.1084/jem.79.2.137.
56. Hakansson A, Roche H, Mirza S, McDaniel LS, Brooks-Walter A, Briles DE. 2001. Characterization of binding of human lactoferrin to pneumococcal surface protein A. Infect. Immun. 69:3372-3381. http://dx.doi.org/10.1128/IAI.69.5.3372-3381.2001.
57. Romero-Steiner S, Libutti D, Pais LB, Dykes J, Anderson P, Whitin JC, Keyserling HL, Carlone GM. 1997. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin. Diagn. Lab. Immunol. 4:415-422.